Spruce Biosciences (SPRBD) Earnings Date & Reports

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SPRBD is expected to report earnings to fall 93.86% to -21 cents per share on November 17

Spruce Biosciences SPRBD Stock Earnings Reports

Q3'25

Est.

$-0.22

Q2'25

Missed

by $3.24

The last earnings report on August 08 showed earnings per share of -350 cents, missing the estimate of -25 cents. With 5.00K shares outstanding, the current market capitalization sits at 4.95M.

View a ticker or compare two or three

Compare

SPRBD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SPRBD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRBD showed earnings on August 08, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details